The pro-oncogenic effects of MPO in lung cancer, namely enhanced cellular proliferation and reduced apoptosis, were mediated by the activation of the AKT and ERK signaling pathways via increased phosphorylation [143]. Here, AKT1 is linked to lung carcinoma.